ArticleGeroScience2026
Gait speed and domain-specific cognitive performance in a diverse cohort of the oldest-old: the LifeAfter90 Study.
Article in GeroScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Gait speed is a robust marker of health in older adults and is associated with cognition, yet few studies have examined this in the oldest-old and if there are differences by cognitive domain. We examined the association between gait speed and cognition across three domains in individuals aged 90 + , considering differences by gender and device use. Then, 502 participants were included from the LifeAfter90 Study. Baseline gait speed (meters/second) was measured using the 4-meter walk test. The Spanish and English Neuropsychological Assessment Scale assessed executive function (EF), verbal episodic memory (VEM), and semantic memory (SM). We tested cross-sectional and longitudinal associations of gait speed with cognition using linear mixed-effects models adjusted for age, gender, race/ethnicity, education, device, interview mode, and practice effects. Models were stratified by gender and device. Participants' mean age was 92.9 ± 2.4 years, 62.6% female, 22.3% African American/Black, 20.9% Asian, 12.3% Hispanic/Latino, 35.9% White, and 8.6% multiracial/other. Faster gait speed was associated with better EF (β(95%CI) = 1.3 (0.9, 1.8)), VEM (0.7 (0.1, 1.2)), and SM (0.8 (0.4, 1.3)). Gender-stratified models showed better EF and SM in both sexes and better VEM in women. Device-stratified models showed better EF and SM in both groups and better VEM in nondevice users. Longitudinally, faster gait speed was associated with slower SM decline (0.1 (0.0003, 0.2)). No other longitudinal associations were significant in pooled or stratified analyses. Faster baseline gait speed was linked to better cognitive performance and slower SM decline. Findings varied by domain, gender, and device use, highlighting gait speed's utility in reflecting cognitive variability among those with exceptional longevity.
Indexed as
Identifiers
41936713What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.